2nd Quarter - Report

VIZIENT, INC. for VIZIENT INC

Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Not-for-Profit Hospital Tax Exemption - conducted outreach and education on hospital tax-exemption and community benefit requirements.

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

Hospital Group Purchasing - Advocated in support of hospital group purchasing organizations and maintaining the GPO safe harbor. 340B Drug Pricing Program - Supported maintaining adequate reimbursement for hospitals purchasing prescription drugs through the 340B Drug Pricing Program. Advocated for preserving the current structure of the program and retaining the current prime vendor. Prescription Drug Pricing - Held Congressional briefing to highlight how hospitals are responding to high drug prices. Urged passage of legislation that would promote competition among prescription drug manufacturers: The CREATES Act (H.R. 965; S. 340); the FAST Generics Act (H.R. 985); the Biologic Patent Transparency Act (S.659); the Affordable Prescriptions for Patients Act (S. 1416); Surprise Billing - Monitored proposals to protect patients from receiving surprise medical bills. Urged inclusion of provisions that would provide for independent dispute resolution in legislation (H.R. 3630 -the No Surprises Act; S. 1895 - The Lower Health Care Costs Act).

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: S. 1895 (116th), H.R. 965 (116th), H.R. 3630 (116th), S. 340 (116th), H.R. 985 (116th), S. 659 (116th), S. 1416 (116th)

Medicare/Medicaid MMM

Medicaid Disproportionate Share Hospital (DSH) Payments - Urged Congress to approve legislation to delay implementation of Medicaid DSH payment cuts. Site-neutral Payments - Supported passage of the PLACE Act (H.R. 2552) which would reverse site-neutral payments cuts implemented by the Centers for Medicare and Medicaid Services. Resident Physician Shortage Reduction Act (S. 348) - Supported passage of the Resident Physician Shortage Reduction Act to support an increase in the number of Medicare-supported graduate medical education residents. Home Infusion Therapy Reimbursement - Opposed CMS's implementation of unnecessary payment restrictions around Medicare's home infusion benefit. Urged Congress to act to expand access to home infusion therapy.

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 2552 (116th), S. 348 (116th)

Tariff (miscellaneous tariff bills) TAR

Tariffs on Medical Supplies - Raised concerns about potential implementation of tariffs on medical devices, device components and active pharmaceutical ingredients. Urged trade negotiators to consider impact on U.S. health care costs.

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.